Mysterious Company Drops Patent Challenge To Sanofi-Aventis' Plavix

Law360, New York (August 5, 2005, 12:00 AM EDT) -- An obscure Scottish company that had filed a mysterious challenge to the U.K. patent covering Sanofi-Aventis’ best-selling blood thinner Plavix has dropped its lawsuit, Sanofi-Aventis said Friday.

“Today Sanofi-Aventis announced that Aircoat has withdrawn the revocation action by which it had sought to invalidate the Sanofi-Aventis patent in the U.K.,” Sanofi said in a statement.

Aircoat, which is based in Scotland, started legal proceedings against Sanofi-Aventis in January this year in an attempt to overturn the patent for clopidogrel bisulfate, the main ingredient in its Plavix...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.